surmount 1 tirzepatide weight loss surmount-1 results percent weight loss 72 weeks These retrospective data from our SURMOUNT‐1 study design. This is

These findings provide a logical means by which peptideantibody conjugates can trigger changes in brain activity

Scenario 1 (Planned Corticosteroid Knee Injection): A patient presents for a pre-planned right knee corticosteroid injection for osteoarthritis (M17.11)

Medium-term effects of semaglutide: Medium-term effects of semaglutide begin around weeks 5 to 20

Type 2 Diabetes Orforglipron ACHIEVE-3 showed orforglipron 36 mg was superior to oral semaglutide 14 mg for HbA1c reduction in a head-to-head Phase 3 trial

Due to its positive outcomes, healthcare professionals are exploring Ozempic as a treatment for weight management